姜黄素
生物利用度
药物输送
背景(考古学)
化学
核酸
适体
指数富集配体系统进化
药理学
组合化学
纳米技术
抗氧化剂
水溶液
DNA
寡核苷酸
靶向给药
生物化学
基因传递
药品
输送系统
溶解度
纳米生物技术
体内
作者
Shaoyun Chen,Yuchen Liu,Siying Ma,Lin Chen,Liping Zhou,Jiawen Wang,Yingying Huang,Zhi‐Ling Yu,Xiaobing Dou
出处
期刊:Drug Delivery
[Taylor & Francis]
日期:2025-11-09
卷期号:32 (1): 2576222-2576222
被引量:6
标识
DOI:10.1080/10717544.2025.2576222
摘要
Curcumin is renowned for anti-inflammatory, antioxidant and hepatoprotective effects, and has been implicated in the amelioration of obesity and diabetes. Notwithstanding its considerable therapeutic potential, the clinical utility of curcumin is hampered by its suboptimal bioavailability, due to poor aqueous solubility and chemical instability. Consequently, the development of strategies to enhance the aqueous solubility, stability, and ultimately, the bioavailability of curcumin has been a focal point of intense research. This study harnessed tetrahedral framework nucleic acids (tFNAs), a relatively simple DNA nanostructure, to encapsulate curcumin. Meanwhile, novel aptamers for liver-specific targeting were acquired by SELEX (Systematic Evolution of Ligands by Exponential Enrichment) method. By capitalizing on the unique properties of aptamers and tFNAs, an aptamer-mediated liver-targeted curcumin delivery system was constructed, with the goal of providing a more efficacious therapeutic approach for non-alcoholic fatty liver disease (NAFLD). This innovative delivery platform has not only markedly improved the solubility and stability of curcumin but has also significantly bolstered its therapeutic efficacy in the context of NAFLD. This research not only offers a novel approach for the delivery of curcumin but also presents a new therapeutic modality for NAFLD. Moreover, the implications of this research extend beyond curcumin, offering a blueprint for the liver-targeted delivery of other drug molecules.
科研通智能强力驱动
Strongly Powered by AbleSci AI